MDMA could enhance psychotherapy outcomes in people with PTSD
In a blinded, randomised phase II trial published in Lancet Psychiatry (1 May 2018), researchers tested the efficacy of MDMA-assisted psychotherapy in 26 veterans and emergency service members with chronic PTSD.
“MDMA-assisted psychotherapy with 75mg or 125mg resulted in marked improvement of PTSD symptoms in veterans and first responders with chronic PTSD who had failed previous treatment,” the researchers concluded.
Original Article (Pharmaceutical Journal):
MDMA could enhance psychotherapy outcomes in people with PTSD
Artwork Fair Use: Oregon Department of Transportation
